Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 79.42M | 73.91M | 71.20M | 64.20M | 65.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.42M | 73.91M | 71.20M | 64.20M | 65.11M |
| Cost of Revenue | 24.17M | 22.21M | 18.84M | 16.14M | 20.92M |
| Gross Profit | 55.25M | 51.70M | 52.36M | 48.06M | 44.19M |
| SG&A Expenses | 49.19M | 47.86M | 47.74M | 48.53M | 51.51M |
| Depreciation & Amortization | 2.53M | 2.51M | 1.89M | 2.30M | 2.79M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.60M | 80.17M | 76.27M | 76.46M | 86.12M |
| Operating Income | -4.19M | -6.26M | -5.08M | -12.27M | -21.02M |
| Income Before Tax | -7.77M | -10.52M | -696.00K | -14.65M | -13.02M |
| Income Tax Expenses | -145.00K | -142.00K | -244.00K | -101.00K | -99.00K |
| Earnings from Continuing Operations | -7.62 | -10.37 | -0.45 | -14.55 | -12.93 |
| Earnings from Discontinued Operations | -2.79M | -9.81M | -47.15M | -60.48M | -51.58M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.41M | -20.18M | -47.60M | -75.03M | -64.51M |
| EBIT | -4.19M | -6.26M | -5.08M | -12.27M | -21.02M |
| EBITDA | 3.25M | 2.07M | 4.26M | -2.07M | -10.12M |
| EPS Basic | -0.23 | -0.45 | -1.05 | -1.68 | -1.46 |
| Normalized Basic EPS | -0.05 | -0.09 | -0.07 | -0.18 | -0.30 |
| EPS Diluted | -0.24 | -0.46 | -1.05 | -1.68 | -1.46 |
| Normalized Diluted EPS | -0.05 | -0.09 | -0.07 | -0.18 | -0.30 |
| Average Basic Shares Outstanding | 185.96M | 184.26M | 182.43M | 179.83M | 177.27M |
| Average Diluted Shares Outstanding | 187.35M | 185.64M | 182.43M | 179.83M | 177.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |